< IP News

Longer Patent Terms for Canadian Pharmaceuticals Now In Effect

Health Canada has issued the first Certificate of Supplementary Protection (CSP) since new provisions providing for such protection came into force on 21 September 2017.  The CSP was granted to Wyeth Holdings LLC in respect of Canadian patent No. 2463476 pertaining to a novel immunogenic composition for the prevention and treatment of meningococcal disease.  The CSP effectively extends the period of patent protection for this composition by two years.

A CSP provides an additional period of patent protection of up to two years for drugs containing a new medicinal ingredient or a new combination of medicinal ingredients.  More information on CSPs can be found in our previous article on the subject.  Eleven other applications for CSPs are pending.

Information made available on this website in any form is for information purposes only. It is not, and should not be taken as legal advice. You should not rely on, or take or fail to take any action, based upon this information. Never disregard professional legal advice or delay in seeking legal advice because of something you have read on this website. Oyen Wiggs Green & Mutala LLP professionals will be pleased to discuss resolutions to specific legal concerns you may have.